Publications by authors named "Ruofei Yu"

Claim this Profile
C
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer.
Geyun Chang, Weihua Li, Hua Bai, Jianchun Duan, Zhijie Wang, Ruofei Yu

Thorac Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.
Pei Zhang, Yang Du, Hua Bai, Zhijie Wang, Jianchun Duan, Ruofei Yu

BMC Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Ruofei Yu, Hua Bai, Tangai Li, Bingyu Gao, Jiefei Han, Geyun Chang

Transl Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.
Jiefei Han, Ruofei Yu, Jianchun Duan, Jin Li, Wei Zhao, Yuqi Wang

Sci Adv· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Pei Zhang, Jianchun Duan, Hua Bai, Zhijie Wang, Shugeng Gao, Yushun Gao, Ruofei Yu

Thorac Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K/AKT apoptosis-inhibiting pathway.
Ruofei Yu, Hua Bai, Bingyu Gao, Tangai Li, Xiran He

Thorac Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.
Yuwei Liao, Zhaokui Ma, Yu Zhang, Dan Li, Dekang Lv, Yue Wang, Ruofei Yu, Yulong Li

Cancer Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Qiang Du, Ruofei Yu, Han Wang, Dong Yan, Qi Yuan

Clin Respir J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Construction of a Multi-Organ Microfluidic Chip Mimicking the in vivo Microenvironment of Lung Cancer Metastasis.
Zhiyun Xu, Encheng Li, Zhe Guo, Ruofei Yu, Hualong Hao, Jianxin Lyu

ACS Appl Mater Interfaces· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and treatment of multiple endocrine neoplasia type 2A: a case report and literature review].
Ruofei Yu, Ziqing Wu, Aimin Li, Guoping Jin, Rongcheng Luo

Nan Fang Yi Ke Da Xue Xue Bao· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancer.
Jianpeng Chen, Yi Luan, Ruofei Yu, Zheng Zhang, Jinbiao Zhang

Biosci Trends· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis